基质金属蛋白酶与动脉粥样硬化

被引:4
作者
沈琳
马亚兵
高海青
机构
[1] 山东大学齐鲁医院老年病科
关键词
基质金属蛋白酶; 动脉粥样硬化; 细胞外基质;
D O I
暂无
中图分类号
R543 [血管疾病];
学科分类号
摘要
基质金属蛋白酶 (MMP)降解细胞外基质 (ECM ) ,参与动脉粥样硬化 (AS)的细胞外基质重构过程 ,与AS的形成、斑块破裂及再狭窄密切相关。适度调节金属蛋白酶的活性为防治AS提供了新的靶点。
引用
收藏
页码:69 / 71
页数:3
相关论文
共 20 条
[1]  
Evidence for increased collagenolysis by interstirial collagenases-1 and-3 in vulnerable human atheromatous plaques. Sukhova GK,Schubecku,Rabkin E,et al. Circulation . 1999
[2]  
Membrance type 1 matrix metalloproteinase expression in human atherosclerotic plaques:evidence for activation by proinflammatory mediators. Rajavashish TB,Xu Xp,Jovinge S. Circulation . 1999
[3]  
Peripheral bloods levels of matrix metalloproteinase-9 and-2 are elevated in patients with acute coronary syndromes. Hisashi Kai,Hisao Ikoda,Hida,et al. J. Am Coll Cardiac . 1998
[4]  
Matrix metalloproteinase. Hideaki N,Frederick W. Journal of Biological Chemistry . 1999
[5]  
New insights into the world of MMPS. Fenans VJ. Circulation . 2002
[6]  
Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. Son JW,Koh KK,Ahn JY,et al. International Journal of Cardiology . 2003
[7]  
Matrix metalloproternases in patients with myocardiac infarction and percutaneous revasularization. Eckart RE,Uyehara CF,Shry EA,et al. Journal of Interventional Cardiology . 2004
[8]  
Plasma concentrations and genetic variation of matrix metalloproteinase-9 and prognosis of patients with cardiovascular disease. Blankenberg S,Rupprecht HJ,Poirier O,et al. Circulation . 2003
[9]  
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[10]  
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24